Language selection

Search

Details for: ALPROLIX

Company: SANOFI-AVENTIS CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02422913ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN500 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02422913ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN500 UNIT / VIALKITINTRAVENOUS
02422921ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN1000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02422921ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN1000 UNIT / VIALKITINTRAVENOUS
02422948ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN2000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02422948ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN2000 UNIT / VIALKITINTRAVENOUS
02422956ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN3000 UNIT / VIALPOWDER FOR SOLUTIONINTRAVENOUS
02422956ALPROLIXRECOMBINANT HUMAN COAGULATION FACTOR IX, FC FUSION PROTEIN3000 UNIT / VIALKITINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Summary Reports

Summary Basis of Decision
Regulatory Decision Summary

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.